[ Price : $8.95]
U.S. health officials order a temporary pause on the use of the chikungunya vaccine Ixchiq in individuals aged 60 and older follow...[ Price : $8.95]
FDA grants Beam Therapeutics a Regenerative Medicine Advanced Therapy designation for BEAM-302, a gene therapy designed to correct...[ Price : $8.95]
New CBER director Vinay Prasad defends his past criticisms of vaccines and says he is not anti-vax and promises that the Center wi...[ Price : $8.95]
FDA grants MeiraGTx Holdings a regenerative medicine advanced therapy designation for gene therapy AAV-GAD and its use for treatin...[ Price : $8.95]
FDA prepares to begin negotiation sessions in September to reauthorize the Prescription Drug User Fee Act, which expires 9/2027.[ Price : $8.95]
FDA commissioner Marty Makary says discussions are continuing with Novavax on its BLA to convert a 2022 emergency use authorizatio...[ Price : $8.95]
Paradigm Therapeutics plans an NDA submission in the second half of this year for Zorblisa (SD-101), as a topical whole-body treat...[ Price : $8.95]
FDA approves a Teal Health PMA for the Teal Wand, the first at-home vaginal sample, self-collection device for cervical cancer scr...